← Thomas Pilgrim

Papers by Thomas Pilgrim

Page 2 · newest first

51. Less Symptom Improvement in Patients Undergoing TAVI With Concomitant COPD, Atrial Fibrillation and Heart FailureCatheterization and Cardiovascular Interventions · 2025
52. Single vs. dual antiplatelet therapy in patients with severe peripheral arterial disease undergoing transcatheter aortic valve implantation: insights from the Hostile registryEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2025
53. Long‐Term Durability of Transcatheter Aortic Valves in Patients With Bicuspid Aortic StenosisCatheterization and Cardiovascular Interventions · 2025
54. Mortality after transcatheter aortic valve replacement in young multimorbid patients as compared to an age-, gender- and comorbidity-matched background populationFrontiers in Cardiovascular Medicine · 2025
55. Impact of Noncoaxial Transcatheter Aortic Valve Implantation on Clinical OutcomesJACC Advances · 2025
56. Incidence, predictors and clinical impact of upper gastrointestinal bleeding after transcatheter aortic valve replacementHeart · 2025
57. Clinical Outcomes in Patients With Acute Pulmonary Embolism Undergoing Ultrasound‐Assisted Catheter‐Directed ThrombolysisJournal of the American Heart Association · 2025
58. The Association of Heart Failure and Liver T1 Mapping in Cardiac Magnetic Resonance ImagingDiagnostics · 2025
59. The Impact of Frailty on VARC-3 Integrated Outcomes in Patients Undergoing Transcatheter Aortic Valve ReplacementJACC Advances · 2025
60. A scoping review evaluating the current state of gut microbiota and its metabolites in valvular heart disease physiopathologyEuropean Journal of Clinical Investigation · 2025
61. Hemodynamic Valve Deterioration After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions · 2025
62. Echocardiographic nomograms in children living at high altitude according to sexEuropean Heart Journal - Imaging Methods and Practice · 2025
63. Clinical Characteristics and Outcomes of Patients Undergoing 3 Aortic Valve InterventionsJACC: Cardiovascular Interventions · 2025
64. Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter ManagementCirculation · 2024
65. Flow Status-Based Predicted Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement With a Balloon-Expandable ValveStructural Heart · 2024
66. Cardiovascular Involvement in Tuberculosis Patients Treated in Southern AfricaJACC Advances · 2024
67. Five‐year outcomes with self‐expanding versus balloon‐expandable TAVI in patients with left ventricular systolic dysfunctionAmerican Heart Journal · 2024
68. Percutaneous Valvular and Structural Heart Disease Interventions.2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of CardiologyEuroIntervention · 2024
69. Timing of Aortic Valve Intervention in the Management of Aortic StenosisJACC: Cardiovascular Interventions · 2024
70. Multimodality Imaging in the Management of Tricuspid Valve RegurgitationEchocardiography · 2024
71. Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVRJACC: Cardiovascular Interventions · 2024
72. Findings from transoesophageal echocardiographic follow-up after mitral transcatheter edge-to-edge repairEuroIntervention · 2024
73. Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosisEuropean Journal of Nuclear Medicine and Molecular Imaging · 2024
74. Incidence and predictors of continued ascending aortic dilatation after TAVI in patients with bicuspid aortic stenosisClinical Research in Cardiology · 2024
75. Comment on Risk of Cardiac Arrhythmias Among Climbers on Mount Everest—ReplyJAMA Cardiology · 2024
76. Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve ReplacementJACC Advances · 2024
77. Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Who Have Undergoing Transcatheter Aortic Valve ReplacementCanadian Journal of Cardiology · 2024
78. Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve ImplantationJournal of Clinical Medicine · 2024
79. Challenges in the Lifetime Management of Patients with Aortic StenosisCardiovascular Medicine · 2024
80. Sex-Specific Differences in Upstream Cardiac Damage in Patients With Aortic Stenosis Undergoing TAVRJACC: Cardiovascular Interventions · 2024
81. Ultrathin-strut versus thin-strut stent healing and outcomes in preclinical and clinical subjectsEuroIntervention · 2024
82. Risk of Cardiac Arrhythmias Among Climbers on Mount EverestJAMA Cardiology · 2024
83. Is Dental Clearance before Cardiac Surgery Necessary?Cardiovascular Medicine · 2024
84. Myocardial analysis from routine 4D cardiac-CT to predict reverse remodeling and clinical outcomes after transcatheter aortic valve implantationEuropean Journal of Radiology · 2024
85. Transcatheter aortic valve implantation for left ventricular assist device-related aortic regurgitationEuropean Journal of Cardio-Thoracic Surgery · 2024
86. Total Muscle Area and Visceral Adipose Tissue Measurements for Frailty Assessment in TAVR PatientsJournal of Clinical Medicine · 2024
87. Total Muscle Area and Visceral Adipose Tissue Measurements for Frailty Assessment in TAVR Patients2024
88. One-year clinical outcomes of transcatheter aortic valve implantation with the latest iteration of self-expanding or balloonexpandable devices: insights from the OPERA-TAVI registryEuroIntervention · 2023
89. Quantitative Flow Ratio to Predict Non–Target‐Vessel Events Before Planned Staged Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeJournal of the American Heart Association · 2023
90. Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic StenosisRadiology · 2023
91. Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVIEuroIntervention · 2023
92. Expansion of Transcatheter Aortic Valve Implantation and Mortality due to Aortic Stenosis Between 2010 and 2019Circulation Cardiovascular Interventions · 2023
93. Combined Significant Aortic Stenosis and Mitral Regurgitation: Challenges in Timing and Type of InterventionCanadian Journal of Cardiology · 2023
94. Antithrombotic Treatment After Transcatheter Valve Interventions: Current Status and Future DirectionsClinical Therapeutics · 2023
95. Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacementEuroIntervention · 2023
96. Effect of timely availability of TTR-stabilizing therapy on diagnosis, treatment initiation, and cardiovascular outcomes in transthyretin amyloid cardiomyopathyEuropean Heart Journal · 2023
97. Sex-Related Outcomes of Transcatheter Aortic Valve Implantation with Self-Expanding or Balloon-Expandable Valves: Insights from the OPERA-TAVI Registry2023
98. Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantationEuroIntervention · 2023
99. Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve ImplantationJournal of the American Heart Association · 2023
100. Impact of COVID-19 Surge Periods on Clinical Outcomes of Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology · 2023